Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -118.97% is 30% below its 5-year average of -91.73%, around the middle of its 5-year range (-162.91%–-28.60%).
As of the fiscal period ended Tuesday, June 30, 2026. 7.53% below its 12-month average of -110.64%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -118.97%.
RETURN ON INVESTED CAPITAL (ROIC)
-118.97%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-110.64%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-115.03%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-91.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-80.53%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-67.26%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-7.53%
CURRENT VS 3Y AVG
-3.42%
CURRENT VS 5Y AVG
-29.69%
CURRENT VS 10Y AVG
-47.73%
CURRENT VS 15Y AVG
-76.88%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
-233.62%
vs the sector median at left
Verastem, Inc.
Market Cap
$681.02M
Return on Invested Capital (ROIC)
-118.97%
TTM Avg
-110.64%
3Y Avg
-115.03%
5Y Avg
-91.73%
Market Cap
$681.27M
Return on Invested Capital (ROIC)
-54.12%
TTM Avg
-85.96%
3Y Avg
-71.51%
5Y Avg
-63.27%
Market Cap
$685.49M
Return on Invested Capital (ROIC)
-41.63%
TTM Avg
-2189.24%
3Y Avg
-1224.39%
5Y Avg
-874.41%
Market Cap
$673.41M
Return on Invested Capital (ROIC)
1.97%
TTM Avg
18.16%
3Y Avg
11.04%
5Y Avg
1.26%
Market Cap
$691.79M
Return on Invested Capital (ROIC)
-50.92%
TTM Avg
-35.84%
3Y Avg
-41.63%
5Y Avg
-32.97%
Market Cap
$693.19M
Return on Invested Capital (ROIC)
-110.62%
TTM Avg
-99.41%
3Y Avg
-74.42%
5Y Avg
-73.36%
Market Cap
$693.61M
Return on Invested Capital (ROIC)
-42.94%
TTM Avg
-42.70%
3Y Avg
-94.89%
5Y Avg
-93.87%
Market Cap
$694.79M
Return on Invested Capital (ROIC)
-12.00%
TTM Avg
-7.53%
3Y Avg
-5.45%
5Y Avg
-2.27%
Market Cap
$666.95M
Return on Invested Capital (ROIC)
-73.27%
TTM Avg
-60.64%
3Y Avg
-63.77%
5Y Avg
-62.42%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Verastem, Inc. (VSTM) | $681.02M | -118.97% | -110.64% | -115.03% | -91.73% |
| Solid Biosciences Inc. (SLDB)vs › | $681.27M | -54.12% | -85.96% | -71.51% | -63.27% |
| Anteris Technologies Global Corp. (AVR)vs › | $685.49M | -41.63% | -2189.24% | -1224.39% | -874.41% |
| MiMedx Group, Inc. (MDXG)vs › | $673.41M | 1.97% | 18.16% | 11.04% | 1.26% |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $691.79M | -50.92% | -35.84% | -41.63% | -32.97% |
| Faeth Therapeutics, Inc. (FTH)vs › | $693.19M | -110.62% | -99.41% | -74.42% | -73.36% |
| Wave Life Sciences Ltd. (WVE)vs › | $693.61M | -42.94% | -42.70% | -94.89% | -93.87% |
| Cytek Biosciences, Inc. (CTKB)vs › | $694.79M | -12.00% | -7.53% | -5.45% | -2.27% |
| Helus Pharma Inc. (HELP)vs › | $666.95M | -73.27% | -60.64% | -63.77% | -62.42% |
| Annexon, Inc. (ANNX)vs › | $660.29M | -101.43% | -70.16% | -61.78% | -52.46% |
ROIC
-119.0%
ROE
-405.5%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -118.97% |
| 2026-03-31 | -102.45% |
| 2025-12-31 | -94.79% |
| 2025-09-30 | -131.94% |
| 2025-06-30 | -105.05% |
| 2025-03-31 | -133.62% |
| 2024-12-31 | -162.91% |
| 2024-09-30 | -115.65% |
| 2024-06-30 | -122.18% |
| 2024-03-31 | -103.15% |
| 2023-12-31 | -74.66% |
| 2023-09-30 | -50.92% |
| 2023-06-30 | -43.17% |
| 2023-03-31 | -75.45% |
| 2022-12-31 | -99.02% |
| 2022-09-30 | -81.37% |
| 2022-06-30 | -86.83% |
| 2022-03-31 | -64.76% |
| 2021-12-31 | -68.18% |
| 2021-09-30 | -62.69% |
| 2021-06-30 | -28.60% |
| 2021-03-31 | -29.67% |
| 2020-12-31 | -35.96% |
| 2020-09-30 | -34.79% |
| 2020-06-30 | -61.39% |
| 2020-03-31 | -67.99% |
| 2019-12-31 | -114.92% |
| 2019-09-30 | -82.24% |
| 2019-06-30 | -68.74% |
| 2019-03-31 | -50.62% |
| 2018-12-31 | -38.55% |
| 2018-09-30 | -58.97% |
| 2018-06-30 | -52.67% |
| 2018-03-31 | -140.79% |
| 2017-12-31 | -93.31% |
| 2017-09-30 | -141.43% |
| 2017-06-30 | -91.53% |
| 2017-03-31 | -66.20% |
| 2016-12-31 | -50.94% |
| 2016-09-30 | -44.87% |
| 2016-06-30 | -49.88% |
| 2016-03-31 | -53.29% |
| 2015-12-31 | -56.51% |
| 2015-09-30 | -53.40% |
| 2015-06-30 | -46.15% |
| 2015-03-31 | -42.04% |
| 2014-12-31 | -59.93% |
| 2014-09-30 | -56.99% |
| 2014-06-30 | -48.51% |
| 2014-03-31 | -41.57% |
| 2013-12-31 | -35.25% |
| 2013-09-30 | -15.35% |
| 2013-06-30 | -25.75% |
| 2013-03-31 | -19.13% |
| 2012-12-31 | -15.13% |
| 2012-09-30 | -31.64% |
| 2012-06-30 | -23.32% |
| 2012-03-31 | -18.08% |
| 2011-12-31 | -24.51% |
